Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NK cell therapy (Aspire Health Science)
- Development stage
- Preclinical
- Lead developer
- Aspire Health Science
- Modality
- CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Lymphokine-Activated Killer Cells → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
NK cell therapy (Aspire Health Science) is an investigational cellular immunotherapy program being developed by Aspire Health Science, a Contract Development and Manufacturing Organization (CDMO). The program focuses on the research and process development of Natural Killer (NK) cells, which are innate immune effector cells capable of identifying and eliminating malignant or virally infected cells. As a CDMO-led program, it represents Aspire's internal development and manufacturing capabilities for allogeneic or autologous NK cell products intended for therapeutic use. The program is currently in the preclinical stage of development, with no specific molecular targets or primary indications currently disclosed.
- Other names
- Natural Killer cellsNK-cells
02
Targets
MICB (Major histocompatibility complex class i-related protein B)IgG Fc (Immunoglobulin G Fc region)NECTIN1 (Poliovirus receptor-related 1)
Beyond the preview
Go deeper on NK cell therapy (Aspire Health Science).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NK cell therapy (Aspire Health Science).